BMS-986325

BIOLOGICAL2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Healthy ParticipantsHealthy VolunteersPrimary Sjögren's Syndrome

Phase 1

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome

TerminatedNCT04684654

Bristol-Myers SquibbHealthy Participants, Primary Sjögren's Syndrome

Start: 2021-02-16End: 2023-07-25Updated: 2023-08-23

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants

CompletedNCT05813717

Bristol-Myers SquibbHealthy Volunteers

Start: 2023-04-10End: 2023-10-02Updated: 2023-11-07